RMNI Showcase
Excellence in Research
Microchip-based devices - Dr. Shana Kelley and her team are developing microchip-based devices to analyze prostate cancer markers in blood.
The big picture - Dr. Albert Stolow and a team of laser experts has solved a 150-year-old problem: how to capture what's going on inside living cells without altering them in any way.
A clear vision - Dr. Brunette and her team are adapting existing laser technology and harnessing the potential of regenerative medicine to address the challenges of entire cornea transplant.
Promoting development in emerging economies - Dr. Abdallah Daar of the McLaughlin-Rotman Centre for Global Health, the University Health Network and the University of Toronto, is leading a research network called RMEthnet that seeks to maximize the potential and minimize the risks of regenerative medicine and nanomedicine worldwide.
A molecular approach to treating heart disease - Angioplasty is a procedure which can leave the surface of the vein or artery vulnerable to the deposition of blood proteins, further narrowing it. Dr. Maryam Tabrizian of McGill University is working at the molecular level to minimize these problems.
A better way to fight type 1 diabetes - Treatment options are limited for people with type 1 diabetes. Dr. Timothy Kieffer of the University of British Columbia is taking a two-pronged, virus-based approach to improving the odds.
Building a better knee - For those suffering from joint disease, artificial knees can turn a painful walk into a pleasure. Dr. Rita Kandel of Mount Sinai Hospital at the University of Toronto and her team have a better idea.
First steps - Training on a treadmill can help people with spinal lesions regain some of their ability to walk, but little is known about the underlying mechanisms. While some of this functional recovery happens naturally, Dr. Serge Rossignol of the University of Montreal has observed that the use of a specific noradrenergic drug initiated patterns of locomotion much earlier.
Safer, gentler gene therapy - Gene therapy is a revolutionary concept with the potential to change the way we treat disease, but getting therapeutic genes into malfunctioning cells isn't easy. Dr. Marianna Foldvari and a team of researchers at the University of Waterloo are harnessing the power of nanotechnology to deliver genes and other therapeutic molecules painlessly to the sites of disease in the body.
Detecting the subtle signs of disease - The human body sends out silent warning signs when health is failing. It could be a change in gene activity or the sudden presence of a tell-tale chemical in the blood. With the help of nanotechnology, Dr. Peter Grutter and a multidisciplinary team of researchers at McGill University are developing tiny sensors that can quickly and accurately pick up the subtle signs of disease.
Electrifying nerve growth - Nerve cells, the delicate communication lines that keep the human body operating, are difficult to re-grow. Peripheral nerve cells, located outside of the brain and spinal cord, do have the ability to rebuild, but regeneration is slow and often incomplete. Dr. Douglas Zochodne of the University of Calgary is helping to change that, bringing new hope to people with nerve damage.
Supplemental content (right column)
- Modified: